JW Pharmaceutical

NCT07442630

Phase 4Active, not recruiting202388 people2 Mar 2026clinicaltrials.gov

NCT07442006

Phase 4Recruiting2025178 people2 Mar 2026clinicaltrials.gov

NCT04584736

Phase 3Completed2019283 people14 Oct 2020clinicaltrials.gov

NCT02940366

CollaboratorPhase 4Status unknown2016500 people20 Oct 2016clinicaltrials.gov

NCT02426723

Phase 1Completed201525 people27 Apr 2015clinicaltrials.gov

NCT01529541

Phase 3Completed2011200 people9 Feb 2012clinicaltrials.gov

NCT01443221

Phase 1Completed201024 people29 Sept 2011clinicaltrials.gov

NCT01422590

CollaboratorPhase 1Completed201026 people24 Aug 2011clinicaltrials.gov

NCT01166633

Phase 4Completed2009200 people21 Jul 2010clinicaltrials.gov

NCT00889226

Phase 4Completed2008161 people28 Apr 2009clinicaltrials.gov

NCT00701285

Phase 4Completed200870 people19 Jun 2008clinicaltrials.gov